Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 19.99
+0.25 (1.27%)
At close: Jul 31, 2026
SHA:688739 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,305 | 1,390 | 1,676 | 1,750 | 1,815 | 2,088 |
Revenue Growth | -21.84% | -17.06% | -4.22% | -3.58% | -13.08% | 4.63% |
Gross Profit Gross Profit Growth | 914.95 | 984.5 | 1,357 | 1,408 | 1,572 | 1,868 |
Operating Income Operating Income Growth | -15.62 | 57.36 | 384.8 | 504.66 | 735.23 | 990.02 |
Net Income Net Income Growth | 57.66 | 131.79 | 342.82 | 465.92 | 714.02 | 892.49 |
Earnings Per Share EPS Growth | 0.14 | 0.32 | 0.83 | 1.12 | 1.71 | 2.34 |
EPS Growth | -82.27% | -61.45% | -25.89% | -34.50% | -26.92% | -4.49% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 1,148 |
Overseas Overseas Growth | 241.92 |
Total Total Growth | 1,390 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,091 | 5,215 | 5,500 | 5,702 | 6,088 | 6,416 |
Total Debt Total Debt Growth | 9.48 | 9.37 | 15.14 | 20.01 | 21.93 | 26.41 |
Net Cash (Debt) Net Cash Growth | 5,082 | 5,206 | 5,484 | 5,682 | 6,066 | 6,390 |
Net Cash Growth | -5.75% | -5.08% | -3.48% | -6.33% | -5.07% | 193.28% |
Net Cash Per Share Net Cash Per Share Growth | 12.58 | 12.64 | 13.28 | 13.66 | 14.53 | 16.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 322.02 | 340.86 | 500.96 | 677.01 | 546.49 | 506.38 |
Capital Expenditures CapEx Growth | -279.57 | -308.08 | -362.48 | -551.99 | -511.61 | -508.35 |
Free Cash Flow Free Cash Flow Growth | 42.45 | 32.78 | 138.48 | 125.02 | 34.89 | -1.97 |
Free Cash Flow Growth | -73.51% | -76.33% | 10.76% | 258.36% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 70.10% | 70.81% | 80.95% | 80.43% | 86.60% | 89.45% |
Operating Margin | -1.20% | 4.13% | 22.96% | 28.84% | 40.51% | 47.41% |
Pretax Margin | 6.95% | 12.20% | 24.04% | 32.93% | 46.17% | 49.38% |
Profit Margin | 4.42% | 9.48% | 20.45% | 26.62% | 39.34% | 42.74% |
FCF Margin | 3.25% | 2.36% | 8.26% | 7.14% | 1.92% | -0.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.100 | 0.800 | 0.800 | 1.000 | 1.000 |
Dividend Per Share Growth | -87.50% | -87.50% | 0% | -20.00% | 0% | - |
Dividend Yield | 0.50% | 0.39% | 3.21% | 2.63% | 3.62% | 1.47% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 140.07 | 80.38 | 30.96 | 29.06 | 17.74 | 35.52 |
Forward PE | 44.42 | 23.69 | 23.60 | 18.60 | - | - |
P/FCF Ratio | 193.67 | 323.16 | 76.63 | 108.30 | 363.13 | - |
PS Ratio | 6.30 | 7.62 | 6.33 | 7.74 | 6.98 | 15.18 |